Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions

被引：8
|
作者：
Carlson, Geoffrey S. [1 ]
Wong, Priscilla H.
White, Kevin M. [2 ]
Quinn, James M. [1 ]
机构：
[1] Wilford Hall, Lackland AFB, TX USA
[2] Royal Air Force Lakenheath, Brandon, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2017年 / 5卷 / 05期
关键词：
VENOM; MEDICATION; SAFETY;
D O I：
10.1016/j.jaip.2017.05.009
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1430 / 1432
页数：3
相关论文
共 50 条
  • [21] Beneficial Effects of Combination Therapy with Angiotensin II Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor on Vascular Endothelial Function
    Satoshi Morimoto
    Kei Maki
    Yasuko Aota
    Takao Sakuma
    Toshiji Iwasaka
    Hypertension Research, 2008, 31 : 1603 - 1610
  • [22] Beneficial Effects of Combination Therapy with Angiotensin II Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor on Vascular Endothelial Function
    Morimoto, Satoshi
    Maki, Kei
    Aota, Yasuko
    Sakuma, Takao
    Iwasaka, Toshiji
    HYPERTENSION RESEARCH, 2008, 31 (08) : 1603 - 1610
  • [23] Vascular protective effects of combined therapy of angiotensin receptor blocker and angiotensin-converting enzyme inhibitor in essential hypertension.
    Morimoto, Satoshi
    Tokoro, Toshiko
    Kikuchi, Sanae
    Yamahara, Hideki
    Imada, Takanobu
    Kohno, Keiko
    Masaki, Hiroya
    Takahashi, Nobuyuki
    Nishikawa, Mitsushige
    Iwasaka, Toshiji
    JOURNAL OF HYPERTENSION, 2006, 24 : 190 - 190
  • [24] Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis
    Woo, Keng-Thye
    Lau, Yeow-Kok
    Chan, Choong-Meng
    Wong, Kok-Seng
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2008, 37 (05) : 372 - 376
  • [25] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    Boenner, G.
    Bakris, G. L.
    Sica, D.
    Weber, M. A.
    White, W. B.
    Perez, A.
    Cao, C.
    Handley, A.
    Kupfer, S.
    JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (08) : 479 - 486
  • [26] Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention
    Ann, Soe Hee
    Strauss, Martin H.
    Park, Gyung-Min
    Han, Seungbong
    Yang, Yujin
    Kim, Yong-Giun
    Won, Ki-Bum
    Kim, Shin-Jae
    Lee, Sang-Gon
    Cho, Young-Rak
    Kim, Dae-Won
    Park, Mahn-Won
    Her, Sung Ho
    Lee, Seung-Whan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 306 : 35 - 41
  • [27] Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
    Molnar, Miklos Z.
    Kalantar-Zadeh, Kamyar
    Lott, Evan H.
    Lu, Jun Ling
    Malakauskas, Sandra M.
    Ma, Jennie Z.
    Quarles, Darryl L.
    Kovesdy, Csaba P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 650 - 658
  • [28] Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor
    Sleight, Peter
    JOURNAL OF HYPERTENSION, 2009, 27 : S23 - S29
  • [29] Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient
    Jarred, Ghassan
    Kennedy, R. Lee
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2010, 1 (01) : 23 - 28
  • [30] Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria
    Chu, Chi D.
    Powe, Neil R.
    McCulloch, Charles E.
    Banerjee, Tanushree
    Crews, Deidra C.
    Saran, Rajiv
    Bragg-Gresham, Jennifer
    Morgenstern, Hal
    Pavkov, Meda E.
    Saydah, Sharon H.
    Tuot, Delphine S.
    HYPERTENSION, 2021, 77 (01) : 94 - 102
12345